UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40431 DAY ONE BIOPHARMACEUTICALS, INC. (Exact name of Registrant as specified in its Charter) Delaware 83-2415215 (State or other jur ...

Financial Performance - Total revenue for the year ended December 31, 2025, was $692.5 million, representing a year-over-year increase of 38.5% from 2024 and 73.7% from 2023[153] - Net income for the year ended December 31, 2025, was $99.3 million, compared to a net loss of $51.3 million for the year ended December 31, 2023[153] - Adjusted EBITDA for the year ended December 31, 2025, was $94.6 million, up from $58.2 million in 2024[153] - Revenue for the year ended December 31, 2025, increased by $192.3 million, or 38.5%, to $692.5 million from $500.2 million in 2024, primarily driven by growth in the automotive vertical[188] - Adjusted EBITDA for 2025 was $94.6 million, compared to $58.2 million in 2024, reflecting a significant improvement in operating performance[185] - Net income for 2025 was $99.3 million, a substantial increase from $32.2 million in 2024, reversing a loss of $51.3 million in 2023[185] Revenue Sources - Revenue from automotive insurance providers accounted for 91% of total revenue in 2025, with the two largest customers contributing 38% of total revenue[154] - The company generated $629.8 million in revenue from automotive insurance in 2025, up from $446.1 million in 2024[166] Future Projections - The company expects overall revenue to increase in 2026, driven by growth in the automotive and home and renters verticals[166] Expenses - Sales and marketing expenses rose by $153.3 million, or 39.5%, to $541.0 million in 2025, largely due to increased advertising costs[190] - Research and development expenses increased by $2.0 million, or 6.6%, to $31.5 million in 2025, driven by higher personnel-related costs[191] - General and administrative expenses grew by $3.8 million, or 12.6%, to $34.1 million in 2025, primarily due to increased stock-based compensation and professional fees[192] - Cost of revenue decreased by $1.5 million, or 7.4%, to $19.4 million in 2025, resulting in a lower percentage of revenue at 2.8% compared to 4.2% in 2024[189] Tax and Interest - The effective tax rate for 2025 was (60.6%), significantly lower than the 5.4% rate in 2024, due to a valuation allowance release of $48.5 million[195] - Interest income increased to $3.6 million in 2025 from $2.1 million in 2024, attributed to higher invested cash balances[194] Marketing and Investment - The company reported variable marketing dollars of $191.9 million in 2025, up from $155.2 million in 2024, indicating increased marketing investment[187] - Variable marketing dollars increased to $191.9 million in 2025, up by $36.6 million or 23.6% from $155.2 million in 2024[196] Cash and Financing - Cash and cash equivalents as of December 31, 2025, were $171.4 million, with an additional $60.0 million available under a revolving line of credit[198] - The company entered into a new $60.0 million senior secured revolving credit facility on August 1, 2025, replacing a prior $25.0 million facility[199] - Net cash provided by operating activities was $95.4 million for the year ended December 31, 2025, compared to $66.6 million in 2024[205] - The company capitalized $4.6 million in software development costs during 2025, up from $2.8 million in 2024[209] Shareholder Actions - A share repurchase program was authorized for up to $50.0 million, with $21.0 million repurchased by August 2025[202] Commitments and Obligations - The company has a minimum lease payment obligation of $2.8 million under non-cancelable operating leases as of December 31, 2025[213] - A five-year, $18.5 million purchase commitment for advertising was entered into in June 2025, with $15.5 million remaining as of December 31, 2025[214] Financial Stability - The company believes existing cash and cash equivalents will be sufficient to fund operating expenses for at least the next 12 months[203] - As of December 31, 2025, the company had no outstanding borrowings under its credit facility, resulting in no material exposure to interest rate fluctuations[223] - The company has exposure to foreign currency exchange rate fluctuations due to contracts with vendors in foreign countries and foreign subsidiaries, but considers this exposure to be immaterial[224]

Exhibit 99.1 CCC Intelligent Solutions Holdings Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results February 24, 2026 – CCC Intelligent Solutions Holdings Inc. ("CCC" or the "Company") (NASDAQ: CCC), a leading SaaS platform provider for the multi-trillion-dollar insurance economy, today announced its financial results for the three months and year ended December 31, 2025. "CCC closed out 2025 with solid financial performance, delivering 12% year-over-year revenue growth and an adjusted EBIT ...

Exhibit 99.1 February 24, 2026 Zeta Global Reports 18th Straight "Beat and Raise" Quarter and Record Full Year 2025 Results NEW YORK – Zeta Global (NYSE: ZETA), the AI Marketing Cloud, today announced financial results for the fourth quarter and full year ended December 31, 2025. "We delivered our 18th consecutive beat-and-raise quarter," said David A. Steinberg, Co-Founder, Chairman, and CEO of Zeta. "This consistent performance is not the result of a single product cycle or an easy comparison. It reflects ...

Exhibit 99.1 CoStar Group™ CoStar Group Full Year 2025: Revenue Increased 19% Year-over-Year; Net Income of $7 million; Adjusted EBITDA of $442 million, up 83% Year-over- Year; Record Net New Bookings of $308 million; $700 million Share Repurchase in 2026 ARLINGTON, VA - February 24, 2026 - CoStar Group, Inc. (NASDAQ: CSGP), a leading provider of online real estate marketplaces, information, analytics, and 3D digital twin technology in the property markets, announced today that revenue for the year ended De ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (MARK ONE) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39408 Lucid Group, Inc. (Exact name of registrant as specified in its charter) Delaware 85-0891392 (State or other jurisdiction of i ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended January 3, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39110 ONTO INNOVATION INC. (Exact name of registrant as specified in its charter) | Delaware | 94-2276314 | | --- | --- ...

Financial Results - CareDx, Inc. announced preliminary unaudited financial results for the quarter and year ended December 31, 2025[4] - The financial results will be further detailed in the attached press release, which is incorporated by reference[5] Press Release - The press release detailing these results was issued on January 12, 2026[4] Company Information - The company is listed on The Nasdaq Stock Market under the trading symbol CDNA[2] - CareDx, Inc. is not classified as an emerging growth company[3]

Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Commission File No. 000-54899 Carlyle Secured Lending, Inc. (Exact name of Registrant as specified in its charter) (State or other jurisdiction of incorp ...

For the Fiscal Year Ended December 31, 2025 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) OR Commission File Number: 000-11486 ConnectOne Bancorp, Inc. (Exact name of registrant as specified in its charter) (State or Other Jurisdiction of Incorporation or Organization) New Jersey 52-1273725 (IRS Employer Identification Number) 301 Sylvan Avenue Englewood Cl ...